Reed Sinopharm delivers mega healthcare tradeshow, plans more specialised ones

REED Sinopharm is going full steam ahead to tap into China’s burgeoning healthcare industry, which is expected to triple in market size to US$1.2 trillion by 2020, according to a state-issued whitepaper in 2013.

A joint venture between Sinopharm, China’s largest state-owned pharmaceutical group, and global events specialist Reed Exhibitions, the company recently concluded the mega Health Industry Summit (tHIS) in May, a new tradeshow that saw 210,000 visitors from 150 countries in attendance.

Described as an event that will transform the Chinese healthcare industry sector, tHIS is a combination of China’s three top medical equipment and pharmaceutical exhibitions – CMEF, PHARMCHINA and API China. It occupied 290,000m2 of space at the new National Convention & Exhibition Center in Shanghai, with healthcare equipment giants GE, SIEMENS, Philips, Mindray, and United Imaging being among the 6,800 exhibitors.

Commenting on the event, Rachel Duan, president and CEO of GE China, said: “Medical and healthcare equipment manufacturers highly value this platform, all bringing with them the latest and best technology to showcase. All the leading companies in the industry are here, all of the top industry talents are here; there lies the explosive popularity of the event.”

Reed Sinopharm will make tHIS an annual event in Shanghai, with the next edition planned for April 15 to 18, 2016.

The company is further building up its portfolio with shows focusing on specific healthcare segments such as Fibo China in Shanghai, a sister event to Reed’s leading event Fibo in Germany, and the China Dental Show, the most academically recognised event in China.

A spokesperson of Reed Sinopharm told TTGmice e-Weekly: “As the focus and size of the health market grow even further, we are in the best position to serve the widening scope of the industry. From food to pharmaceuticals, exercise equipment to medical equipment, birth to retirement, prevention to rehabilitation, Reed Sinopharm intends to cover the entire value chain, and we want to build a platform to cover the health sector when it becomes one of the driving forces for the Chinese economy.”

By Luke Williams

Sponsored Post